728
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Discovery of a series of small molecules as potent histone deacetylase inhibitors

, , &
Pages 333-337 | Received 31 Jan 2013, Accepted 24 Feb 2013, Published online: 27 Mar 2013

Figures & data

Figure 1. Design of new scaffold from the lead structure.

Figure 1. Design of new scaffold from the lead structure.

Scheme 1. Reagents and conditions: (a) CH3COCl, CH3OH; (b) (Boc)2O, Et3N, MeOH/H2O; (c) RSO2Cl, NaHCO3, THF/H2O; (d) TBTU, Et3N, THF; (e) NH2OK, MeOH; (f) EtOAc, HCl.

Scheme 1. Reagents and conditions: (a) CH3COCl, CH3OH; (b) (Boc)2O, Et3N, MeOH/H2O; (c) RSO2Cl, NaHCO3, THF/H2O; (d) TBTU, Et3N, THF; (e) NH2OK, MeOH; (f) EtOAc, HCl.

Table 1. The inhibitory activities of derived molecules.*

Table 2. The tumor cell growth inhibitory activities of 4h compared with SAHA.*

Figure 2. Binding patterns of 4h and 4hb in the active site of HDAC2: (a) 4h and 4hb were shown using the wire model, the residues were displayed as sticks; carbon atoms of 4h were colored magenta, carbon atoms of 4hb were colored green, the gray ball is zinc ion, the H-bonds were represented as dash lines (in black--white mode, 4h is the structure containing Boc group); (b) 4h was shown using the ball–stick model.

Figure 2. Binding patterns of 4h and 4hb in the active site of HDAC2: (a) 4h and 4hb were shown using the wire model, the residues were displayed as sticks; carbon atoms of 4h were colored magenta, carbon atoms of 4hb were colored green, the gray ball is zinc ion, the H-bonds were represented as dash lines (in black--white mode, 4h is the structure containing Boc group); (b) 4h was shown using the ball–stick model.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.